PubMed · 2000 · 39 citations · 36 references
Life SciencesMolecular BiologyOncologyApoptosisMolecular Cell BiologyMolecular OncologyApoptosis In CancerApoptosis RegulationCancer Cell SignalingCyclin-dependent KinasesSignal Transduction In CancerTumor Suppressor GenesCell Cycle Arrest MechanismsChemotherapy-induced ApoptosisNf-kappa B-dependent TranscriptionNuclear Factor Kappa B SignalingP21 RegulationP53-mediated Cell Cycle RegulationTranscriptional ActivationTranscriptional Activation Elements
Daunomycin is a potent inducer of p53 and NF-kappaB transcription factors. It is also able to increase the amount of the p21 cyclin-dependent kinase inhibitor. The human p21 promoter harbors p53-responsive elements and an NF-kappaB binding site. We demonstrated, in human breast and colon carcinoma cells, the binding of NF-kappaB dimers to the kappaB site and the transcriptional activation of the human p21 promoter by daunomycin and by NF-kappaB subunits, thereby confirming the functionality of this kappaB binding site. However, using different tumor cell lines where p53 or NF-kappaB was inactive, we showed that p21 activation and cell cycle arrest induced by daunomycin was p53-dependent and NF-kappaB-independent, whereas daunomycin-induced apoptosis was p53- and NF-kappaB-independent.
36
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu et al. · Cell · 1993 · 8.4K citations
p21 is a universal inhibitor of cyclin kinases
Yue Xiong, Gregory J. Hannon, Hui Zhang et al. · Nature · 1993 · 3.4K citations
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Amer A. Beg, David Baltimore · Science · 1996 · 3.1K citations